Zdrowie i gospodarka · 02/09/2020
FDA Clears Path for Abbreviated Approval of MICRO-K LS Potassium Chloride Extended-Release Liquid Suspension
The FDA has determined that MICRO-K LS (potassium chloride) extended-release liquid suspension, 20 milliequivalents/packet, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.